EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+7.73%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$436M
AUM Growth
+$436M
(+1.6%)
Cap. Flow
-$4.64M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
65.68%
Holding
29
New
1
Increased
9
Reduced
9
Closed
1
Top Buys
| 1 |
Illumina
ILMN
|
$18M |
| 2 |
IQVIA
IQV
|
$13.4M |
| 3 |
Intuitive Surgical
ISRG
|
$10.5M |
| 4 |
Tandem Diabetes Care
TNDM
|
$9.4M |
| 5 |
Outset Medical
OM
|
$3.49M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$12M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$10.3M |
| 3 |
Humana
HUM
|
$10.2M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$8.62M |
| 5 |
CANO
Cano Health, Inc.
CANO
|
$8.56M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Illumina
ILMN
$15.8B
| $40.7M | 9.34% | 213,201 +94,093 | +79% | +$18M |
|
|
2
IQVIA
IQV
$32.4B
| $36.2M | 8.31% | 199,895 +73,800 | +59% | +$13.4M |
|
3
Alnylam Pharmaceuticals
ALNY
$58.5B
| $32.4M | 7.43% | 161,716 +12,336 | +8% | +$2.47M |
|
4
United Therapeutics
UTHR
$13.8B
| $29.5M | 6.76% | 140,738 -18,500 | -12% | -$3.87M |
|
|
5
Humana
HUM
$36.5B
| $28.7M | 6.58% | 59,091 -21,100 | -26% | -$10.2M |
|
6
Natera
NTRA
$23.1B
| $26.1M | 5.99% | 595,994 +25,000 | +4% | +$1.1M |
|
|
CANO
7
DELISTED
Cano Health, Inc.
CANO
| $24.5M | 5.63% | 2,829,796 -986,916 | -26% | -$8.56M |
|
|
SGEN
8
DELISTED
Seagen Inc. Common Stock
SGEN
| $23.9M | 5.49% | 174,902 -87,600 | -33% | -$12M |
|
|
9
Intuitive Surgical
ISRG
$170B
| $22.8M | 5.23% | 121,630 +56,100 | +86% | +$10.5M |
|
10
DexCom
DXCM
$29.5B
| $21.4M | 4.91% | 265,800 +28,700 | +12% | +$2.31M |
|
11
argenx
ARGX
$43.6B
| $21.3M | 4.89% | 60,300 | – | – |
|
12
AstraZeneca
AZN
$248B
| $20.7M | 4.76% | 377,965 -5,100 | -1% | -$280K |
|
|
13
Outset Medical
OM
$247M
| $19.7M | 4.53% | 1,237,990 +219,030 | +21% | +$3.49M |
|
14
Inspire Medical Systems
INSP
$2.77B
| $17.8M | 4.09% | 100,553 +6,400 | +7% | +$1.14M |
|
15
American Well
AMWL
$111M
| $13M | 2.99% | 3,631,710 -109,703 | -3% | -$394K |
|
|
16
Tandem Diabetes Care
TNDM
$845M
| $9.4M | 2.16% | +196,400 | New | +$9.4M |
|
17
Agios Pharmaceuticals
AGIO
$2.19B
| $9.32M | 2.14% | 329,713 -246,700 | -43% | -$6.98M |
|
18
Adaptive Biotechnologies
ADPT
$2.01B
| $8.65M | 1.99% | 1,214,860 | – | – |
|
19
Guardant Health
GH
$8.41B
| $8.18M | 1.88% | 151,960 | – | – |
|
|
AXNX
20
DELISTED
Axonics, Inc. Common Stock
AXNX
| $7.79M | 1.79% | 110,560 -145,905 | -57% | -$10.3M |
|
|
CMAX
21
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $5.07M | 1.16% | 714,755 | – | – |
|
22
4D Molecular Therapeutics
FDMT
$288M
| $2.96M | 0.68% | 368,411 +106,988 | +41% | +$860K |
|
23
10x Genomics
TXG
$1.74B
| $1.4M | 0.32% | 49,200 -212,000 | -81% | -$6.04M |
|
24
Beam Therapeutics
BEAM
$1.66B
| $1.38M | 0.32% | 28,900 | – | – |
|
25
Arvinas
ARVN
$568M
| $1.02M | 0.23% | 23,000 | – | – |
|